GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 Nov. 5, 2024 9:00 AM ET Source: GeoVax, Inc.
ZenaTech Announces Dual Listing of Its Shares on the Frankfurt Stock Exchange Nov. 4, 2024 7:30 AM ET
ZenaTech Announces Dual Listing of Its Shares on the Frankfurt Stock Exchange Nov. 4, 2024 7:30 AM ET Source: ZenaTech Inc.
Forian Acquires Kyber Data Science to Enhance Data Analytics Capabilities Nov. 1, 2024 9:00 AM ET Source: Forian Inc.
ZenaTech's ZenaDrone Completes the First Phase of an IQ Nano Inventory Management Trial for Multinational Auto Parts Customer Oct. 31, 2024 7:30 AM ET
Kennedy Space Center Visitor Complex joins Orlando CityPASS offering an extraordinary space adventure Oct. 30, 2024 6:00 AM ET Source: CityPASS
Kennedy Space Center Visitor Complex joins Orlando CityPASS offering an extraordinary space adventure Oct. 30, 2024 6:00 AM ET Source: CityPASS
Cavitation Technologies, Inc. Provides Corporate Update and Letter to Shareholders, Goals for Fiscal Year 2025, and Recent Transaction With Desmet Belgium, SA Oct. 28, 2024 9:00 AM ET Source: Cavitation Technologies, Inc
Cavitation Technologies, Inc. Provides Corporate Update and Letter to Shareholders, Goals for Fiscal Year 2025, and Recent Transaction With Desmet Belgium, SA Oct. 28, 2024 9:00 AM ET Source: Cavitation Technologies, Inc
ZenaTech Announces Management Team Promotions to Position for Growth Oct. 25, 2024 7:30 AM ET Source: ZenaTech Inc.
Wytec Announces Its Uplisting Preparation to the Nasdaq Capital Markets in Conjunction With Completing Its AI Gunshot Detection Technology Oct. 24, 2024 2:45 PM ET Source: Wytec International
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners Oct. 24, 2024 2:40 PM ET Source: ABVC BioPharma, Inc.
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners Oct. 24, 2024 2:35 PM ET Source: ABVC BioPharma, Inc.
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 Oct. 24, 2024 2:35 PM ET Source: Hydromer, Inc
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 Oct. 24, 2024 11:21 AM ET Source: Hydromer, Inc
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners Oct. 22, 2024 8:47 AM ET Source: ABVC BioPharma, Inc.
